Hair Library

Hair Library · Hair Loss Treatments

Dutasteride for Hair Loss: How It Works and How It Compares With Finasteride

How dutasteride blocks both enzymes that make DHT, how it compares with finasteride in head-to-head trials, its side effects, and the checks the label asks for before you start.

Diagram: dutasteride blocks both the type 1 and type 2 5-alpha reductase enzymes, while finasteride blocks only type 2, so less DHT is made in the blood and scalp
29sources
28in PubMed
11min read

Written by Nazmi Güldeş, Certified Trichologist · Medically reviewed by Dr. Teuku Adifitrian, Sp.BP-RE (Dr. Tompi), Plastic, Reconstructive and Aesthetic Surgeon · Last reviewed 30 October 2026

Reading level

Dutasteride is a daily capsule that blocks both enzymes your body uses to turn testosterone into DHT, the hormone behind male pattern hair loss.[1] In a trial that randomized 917 men, dutasteride 0.5 mg grew more hair than finasteride 1 mg after 24 weeks.[1] The trade-offs: it lingers in your body for months[2], and its hair loss approvals are in South Korea and Japan, not the United States.[3]

1Quick answerThe short answer, in a few sentences

What Is Dutasteride?

Dutasteride is a prescription 0.5 mg capsule that blocks both type 1 and type 2 5-alpha reductase, the enzymes that make DHT. Blood DHT falls by about 90% within two weeks.[2] It is approved for male pattern hair loss in South Korea and Japan; in the United States it is approved only for an enlarged prostate.[3][2]

It was first approved in the United States in 2001 as Avodart, for benign prostatic hyperplasia.[2] Its use for hair rests on trials showing that blocking both enzymes grows more scalp hair than blocking type 2 alone.[4][1]

It is a medicine for men. Pregnant women must not take it, and women who are or may be pregnant should not even handle the capsules.[2]

2Complete guideFrom the finasteride comparison to safety checks and surgery

Dutasteride vs Finasteride

How Dutasteride Lowers DHT

Your body makes DHTGlossaryDihydrotestosterone (DHT) is a potent androgen that the body makes from testosterone using an enzyme called 5-alpha reductase. In people who are genetically sensitive to it, DHT makes hair follicles shrink.
Open in the glossary →
with 5-alpha reductase, which comes in two forms. Type 2 works mainly in reproductive tissues, while type 1 also works in the skin and liver.[2] Finasteride blocks type 2 only; dutasteride blocks both.[1]

In men treated for an enlarged prostate, median blood DHT stayed 93% to 95% lower for four years.[2] Why DHT thins some follicles and spares others, and how every DHT treatment compares, is covered in our entry on DHT and hair loss.

Dutasteride vs Finasteride: Head-to-Head Results

In the main head-to-head trial, 917 men aged 20 to 50 took dutasteride, finasteride or placebo for 24 weeks.[1]

Dutasteride 0.5 mgFinasteride 1 mg
Enzymes blockedType 1 and type 2[1]Type 2 only[1]
Half-lifeAbout 5 weeks[3]About 4.5 hours[3]
Approved for hair lossMen, in South Korea and Japan[3]Men, approved by the FDA[3]
Hair count at 24 weeks, 917 menSignificantly more hair[1]Less than dutasteride[1]
Network meta-analysis7.1 more hairs per cm² at 24 weeks[5]Largest gain in terminal (thick) hairs at 48 weeks[5]
Sexual side effects against placeboRelative risk 1.37, not significant[6]Relative risk 1.66[6]
Effect on PSAAbout 50% lower[2]40% to 50% lower in men aged 40 to 60[7]

Not every trial agrees. A 2017 trial of 90 men found more new hair and fewer thin, miniaturized hairs on dutasteride[8], and a meta-analysis of 576 men favoured it on hair counts and photographs.[9] A 2026 trial of 46 men with moderate to severe loss found no significant difference after 24 weeks.[10] Weighing 33 studies, a 2025 network meta-analysis still ranked dutasteride 0.5 mg first.[11]

Clinical detail: the numbers behind the comparison

Thin hairs per cm² over 24 weeks fell from 65 to 57 on dutasteride and from 67 to 66 on finasteride.[8] Pooled difference in total hair count: 28.57 (95% CI 18.75 to 38.39).[9]

Dutasteride Results, Side Effects and Mesotherapy

Dutasteride Results Timeline

Dutasteride builds up slowly: blood levels reach 65% of their steady state after one month and about 90% after three.[2]

Time on dutasterideWhat the trials and label show
Weeks 1 to 2Blood DHT is 85% lower after one week and 90% lower after two[2]
Week 12In a 416-man trial, 2.5 mg already beat finasteride 5 mg[4]
Week 24Hair count rose by 12.2 per cm², against 4.7 on placebo, in a trial of 153 men[12]
Week 52Hair count, hair width and overall appearance had improved in 120 Japanese men[13]
Year 589.9% of 99 Korean men were rated improved[14]
After stoppingDutasteride stays measurable in the blood for 4 to 6 months[2]

Improvement in pattern hair loss typically takes at least six months, so judge it no earlier.[15]

Dutasteride Dosage: 0.5 mg and Lower

The standard dose is one 0.5 mg capsule a day, swallowed whole, because the contents can irritate your mouth and throat.[2] A lower dose may be enough: in a 2025 trial of 139 men, 0.2 mg matched 0.5 mg on every efficacy measure at 24 weeks.[16]

Dutasteride Side Effects

In the prostate trials, in men aged 47 to 94, these were the rates in the first six months:[2]

  • Erection problems: 4.7% on dutasteride, 1.7% on placebo
  • Lower sex drive: 3.0% against 1.4%
  • Ejaculation problems: 1.4% against 0.5%
  • Breast tenderness or enlargement: 0.5% against 0.2%

Sexual side effects may continue after stopping; the label says the role of dutasteride in this is unknown.[2]

Hair-loss trials in younger men give a mixed picture. In one 117-man trial, sexual side effects affected 16% on dutasteride and 8% on placebo, all mild to moderate and reversible.[17] A 2026 review put the range at 4.1% to 12.0% on dutasteride, against 4.0% to 5.0% on placebo.[18] Yet the 2019 meta-analysis found no significant rise and called the dutasteride data limited.[6]

Depressed mood is listed among reports received since approval.[2] If your mood drops, tell your doctor; persistent symptoms are covered in our entry on post-finasteride syndrome.

Sperm changes too. After a year, total sperm count was 23% lower and still 23% down 24 weeks after stopping, while the effect on fertility is unknown.[2] If you are trying for a baby, raise it with your doctor.

Dutasteride Mesotherapy and Topical Use

Mesotherapy means injecting a dilute dutasteride solution into the scalp skin, where very little reaches the bloodstream. It is off-label and has no FDA approval.[19]

A 2025 systematic review found denser, thicker hair with few side effects, but small and varied studies.[20] A 2025 network meta-analysis found injections significantly less effective than the capsule.[11] In one series of 15 patients, 4 developed patchy hair loss at the injection sites after a single session[19], and in three women in another report the patches never fully regrew.[21]

Microneedling followed by a dutasteride solution is another local route; both methods still lack standard protocols and large trials.[22]

Before You Start Dutasteride

Is Dutasteride FDA Approved for Hair Loss?

No. In the United States it is approved for an enlarged prostate, and doctors prescribe it for hair off-label.[2][3] Elsewhere:

  • South Korea approved it for male pattern hair loss in 2009.[14]
  • Japan has approved it for men[3], and its guideline lists it as a first-line treatment.[23]
  • Canada: a 2025 expert panel recommends oral dutasteride, while giving scalp injections only near-consensus support.[24]

Blood Donation, Pregnancy and PSA Tests

The label sets out checks that apply whatever the reason you take it:[2]

  1. Blood donation. Wait at least 6 months after your last dose, so a pregnant woman cannot receive dutasteride through a transfusion.[2]
  2. Pregnancy. Women who are or may be pregnant should not handle the capsules, because dutasteride passes through skin and could put a male baby at risk. Wash any contact with a leaking capsule with soap and water.[2]
  3. PSA tests. PSA falls by about 50% within 3 to 6 months, so after three months a single reading is doubled before comparing it with normal values.[2]
  4. Any rise. A confirmed rise from your lowest PSA needs checking, even inside the normal range. Tell whoever orders the test that you take dutasteride.[2]
Diagram: dutasteride builds up in the blood over about three months, stays measurable for 4 to 6 months after the last capsule, and blood donation must wait at least 6 months
How long dutasteride stays in your blood, based on the FDA prescribing information for Avodart.

Dutasteride for Women

Dutasteride is not indicated for women.[2] The Japanese guideline says it is contraindicated for female pattern hair loss[23], though some dermatologists use it off-label.[25]

In frontal fibrosing alopecia, a scarring hair loss, a meta-analysis of 366 patients found it stabilized the disease in about 63%.[26] For pattern thinning, read about female pattern hair loss and spironolactone.

Dutasteride and a Hair Transplant

A transplant moves follicles from the donor areaGlossaryThe donor area is the back and sides of the head, where follicles resist DHT. An extracted follicle does not grow back in that spot, so extractions are spread out, and the donor supply is the limit of every plan.
Open in the glossary →
to thinning zones, but the native hair around the grafts can keep miniaturizing and erode the result.[27]

The surgical trial evidence comes from finasteride: taken from four weeks before to 48 weeks after surgery, it improved hair around the grafts in 79 men.[27] We found no matching trial for dutasteride, so the logic holds but the proof is thinner. See our finasteride entry and our guide to preparing for a hair transplant.

Because surgery cannot stop native hair from thinning[27], it is the wrong first answer when most of your loss is still thinning hair rather than bare scalp. Start with medication and judge it after six months or more.[15]

Frequently Asked Questions

Can you switch from finasteride to dutasteride?
Yes. In 35 Korean men who had not improved on finasteride after six months, 77.4% of those who finished six months of dutasteride improved, with hair density up 10.3%. There was no comparison group.[28]
Can dutasteride regrow a receding hairline?
It can improve the front. In the 917-man trial, an expert panel rated frontal photographs better on dutasteride than on finasteride at 24 weeks.[1]
Does dutasteride cause shedding?
Shedding is not listed among its side effects in the prescribing information.[2] Patchy hair loss after scalp injections is a different problem.[19] If you shed heavily, see your doctor, because telogen effluviumGlossaryTelogen effluvium is sudden diffuse shedding that follows illness, childbirth or stress. Shedding usually starts two to three months after the trigger, and it is usually self-limiting once the trigger is removed.
Open in the glossary →
may be involved.
Does dutasteride lower testosterone?
No. In the prostate trials, median testosterone rose by 19% over two years and stayed in the normal range.[2]
Can dutasteride cause depression?
Depressed mood has been reported since approval.[2] A 2024 meta-analysis of more than 2.2 million patients found no significant link with depression or suicide, for dutasteride as for finasteride.[29]
Can women take dutasteride?
It is not indicated for women and must not be used in pregnancy.[2] Any use in women is off-label.[25]
Can you take dutasteride and minoxidil together?
Yes. Combining minoxidil with a 5-alpha reductase inhibitor such as dutasteride is common in male pattern hair loss.[15] Our minoxidil entry explains how to use it.
Does dutasteride cause prostate cancer?
In a four year trial of 8,231 men aged 50 to 75, high-grade prostate cancer was found in 1.0% on dutasteride and 0.5% on placebo. The label says it may raise that risk.[2]

Is Dutasteride Right for You?

Dutasteride suits men with pattern hair loss who want more DHT suppression than finasteride gives, or who did not respond to it, and who accept a drug that lingers for months.[3][28][2] It is not an option for women who could become pregnant.[2]

If you are weighing dutasteride against finasteride, or a transplant as well, send us three photos for a free hair analysis. The medical team will tell you whether your pattern of loss suits medication, surgery or both. You can also message us on WhatsApp.

About the Author

Written by: Nazmi Güldeş, Certified Trichologist. Nazmi Güldeş focuses on patient education around androgenetic alopecia, evaluating miniaturization through dermoscopy, and assessing candidates for medical treatments and hair transplants.

Editorial Policy & Trust

This entry was drafted with the help of AI writing tools and edited by our team, then medically reviewed by Dr. Teuku Adifitrian, Sp.BP-RE (Dr. Tompi) on 30 October 2026. AI is never used as a source: every study cited here was checked against PubMed on 30 October 2026, and each claim sits next to the study that supports it. Read how we work in our editorial policy.

3 questions

Test yourself

Check what you remember from this entry. Each answer links back to the section that explains it.

  1. How long should you wait to donate blood after your last dutasteride capsule?
  2. In the 917-man trial, how did dutasteride 0.5 mg compare with finasteride 1 mg at 24 weeks?
  3. How did dutasteride injections (mesotherapy) rank against the capsule in a 2025 network meta-analysis?
3Scientific evidenceStudy types, references and how to cite this entry
29sources

Evidence behind this entry: 28 publications indexed in PubMed (2005 to 2026): 9 randomized trials, 8 systematic reviews, 4 reviews, 2 clinical studies, 2 case reports, 2 guidelines and 1 clinical trial. Plus the FDA prescribing information for Avodart (dutasteride 0.5 mg). 9 sources have free full text.

  • Randomized trialpeople assigned to treatments by chance
  • Reviewsummarises many studies
  • Clinical studya study in people without random groups
  • Guideline or labela professional body, or the official drug label

Every source checked against PubMed on 30 October 2026, including corrections and retractions. See the newest studies on PubMed →

References

  1. Gubelin Harcha W, Barboza Martínez J, Tsai TF, et al. A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia. Journal of the American Academy of Dermatology. 2014;70(3):489-498.e3.Randomized trialPubMedDOI
  2. U.S. Food and Drug Administration. AVODART (dutasteride) soft gelatin capsules: prescribing information. Revised January 2020.Drug labelSource page
  3. Gupta AK, Talukder M, Williams G. Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia. The Journal of Dermatological Treatment. 2022;33(7):2946-2962.ReviewPubMedDOI
  4. Olsen EA, Hordinsky M, Whiting D, et al. The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride. Journal of the American Academy of Dermatology. 2006;55(6):1014-1023.Randomized trialPubMedDOI
  5. Gupta AK, Venkataraman M, Talukder M, et al. Relative Efficacy of Minoxidil and the 5-α Reductase Inhibitors in Androgenetic Alopecia Treatment of Male Patients: A Network Meta-analysis. JAMA Dermatology. 2022;158(3):266-274.Systematic reviewPubMedDOIFree full text
  6. Lee S, Lee YB, Choe SJ, et al. Adverse Sexual Effects of Treatment with Finasteride or Dutasteride for Male Androgenetic Alopecia: A Systematic Review and Meta-analysis. Acta Dermato-Venereologica. 2019;99(1):12-17.Systematic reviewPubMedDOI
  7. D'Amico AV, Roehrborn CG. Effect of 1 mg/day finasteride on concentrations of serum prostate-specific antigen in men with androgenic alopecia: a randomised controlled trial. The Lancet Oncology. 2007;8(1):21-25.Randomized trialPubMedDOI
  8. Shanshanwal SJ, Dhurat RS. Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: A randomized controlled open-label, evaluator-blinded study. Indian Journal of Dermatology, Venereology and Leprology. 2017;83(1):47-54.Randomized trialPubMedDOI
  9. Zhou Z, Song S, Gao Z, et al. The efficacy and safety of dutasteride compared with finasteride in treating men with androgenetic alopecia: a systematic review and meta-analysis. Clinical Interventions in Aging. 2019;14:399-406.Systematic reviewPubMedDOIFree full text
  10. Poostiyan N, Nikyar Z, Makhmali R, et al. Efficacy and safety of oral finasteride versus dutasteride in moderate-to-severe androgenetic alopecia in males based on trichoscopic and laboratory findings: a clinical comparison in Iran. The Journal of Dermatological Treatment. 2026;37(1):2583849.Randomized trialPubMedDOI
  11. Gupta AK, Bamimore MA, Williams G, et al. Comparative Efficacy of Minoxidil and 5-Alpha Reductase Inhibitors Monotherapy for Male Pattern Hair Loss: Network Meta-Analysis Study of Current Empirical Evidence. Journal of Cosmetic Dermatology. 2025;24(7):e70320.Systematic reviewPubMedDOIFree full text
  12. Eun HC, Kwon OS, Yeon JH, et al. Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: a randomized, double-blind, placebo-controlled, phase III study. Journal of the American Academy of Dermatology. 2010;63(2):252-258.Randomized trialPubMedDOI
  13. Tsunemi Y, Irisawa R, Yoshiie H, et al. Long-term safety and efficacy of dutasteride in the treatment of male patients with androgenetic alopecia. The Journal of Dermatology. 2016;43(9):1051-1058.Clinical trialPubMedDOI
  14. Choi S, Kwon SH, Sim WY, et al. Long-term efficacy and safety of dutasteride 0.5 mg in Korean men with androgenetic alopecia: 5-year data demonstrating clinical improvement with sustained efficacy. The Journal of Dermatology. 2024;51(5):684-690.Clinical studyPubMedDOI
  15. Iyengar L, Li J. Male and female pattern hair loss. Australian Prescriber. 2025;48(3):93-97.ReviewPubMedDOIFree full text
  16. Lee S, Kim JE, Lew BL, et al. Efficacy and Safety of Low-Dose (0.2 mg) Dutasteride for Male Androgenic Alopecia: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase III Clinical Trial. Annals of Dermatology. 2025;37(4):183-190.Randomized trialPubMedDOIFree full text
  17. Tsai TF, Choi GS, Kim BJ, et al. Prospective randomized study of sexual function in men taking dutasteride for the treatment of androgenetic alopecia. The Journal of Dermatology. 2018;45(7):799-804.Randomized trialPubMedDOIFree full text
  18. Złotowska A, Jastrząb-Miśkiewicz B, Krajewski PK. Sexual dysfunction associated with 5α-reductase inhibitors in the treatment of androgenetic alopecia: a systematic review. Frontiers in Medicine. 2026;13:1787706.Systematic reviewPubMedDOIFree full text
  19. Chandrashekhar M, Chandrashekar BS, Madura C, et al. Paradoxical Nonscarring Alopecia Following Mesotherapy with Dutasteride: A Case Series. International Journal of Trichology. 2025;17(3):209-214.Case reportPubMedDOIFree full text
  20. Almeziny A, Alghamdi A, Alajlan A, et al. Effectiveness and Safety of Intralesional Dutasteride in Patients With Androgenic Alopecia: A Systematic Review and Meta-Analysis. Journal of Cosmetic Dermatology. 2025;24(12):e70560.Systematic reviewPubMedDOIFree full text
  21. Nogueira CM, Osório F. Persistent Alopecic Patches Following Dutasteride Mesotherapy for Female Androgenetic Alopecia: A Case Series. Journal of Drugs in Dermatology. 2026;25(3):951-955.Case reportPubMedDOI
  22. Ding Y, Wang C, Bi L, et al. Dutasteride for the Treatment of Androgenetic Alopecia: An Updated Review. Dermatology (Basel, Switzerland). 2024;240(5-6):833-843.ReviewPubMedDOI
  23. Manabe M, Tsuboi R, Itami S, et al. Guidelines for the diagnosis and treatment of male-pattern and female-pattern hair loss, 2017 version. The Journal of Dermatology. 2018;45(9):1031-1043.GuidelinePubMedDOI
  24. Landells I, Chow E, Gupta AK, et al. A Canadian Consensus on Androgenetic Alopecia: Approach and Management. Journal of Cutaneous Medicine and Surgery. 2025;29(5_suppl):5S-14S.GuidelinePubMedDOI
  25. Kearney CA, Brinks AL, Lawrence CN, et al. Androgenetic Alopecia in Women: A Narrative Review of Pathophysiology, Clinical Evaluation, and Treatments. American Journal of Clinical Dermatology. 2026;27(2):363-389.ReviewPubMedDOI
  26. Seo HM, Oh SU, Kim S, et al. Dutasteride in the treatment of frontal fibrosing alopecia: Systematic review and meta-analysis. Journal of the European Academy of Dermatology and Venereology. 2024;38(8):1514-1521.Systematic reviewPubMedDOI
  27. Leavitt M, Perez-Meza D, Rao NA, et al. Effects of finasteride (1 mg) on hair transplant. Dermatologic Surgery. 2005;31(10):1268-1276, discussion 1276.Randomized trialPubMedDOI
  28. Jung JY, Yeon JH, Choi JW, et al. Effect of dutasteride 0.5 mg/d in men with androgenetic alopecia recalcitrant to finasteride. International Journal of Dermatology. 2014;53(11):1351-1357.Clinical studyPubMedDOI
  29. Uleri A, Nicolas Cornu J, Gobbo A, et al. Association of 5α-Reductase Inhibitors with Depression and Suicide: A Mini Systematic Review and Meta-analysis. European Urology Focus. 2024;10(5):751-753.Systematic reviewPubMedDOI
Written byNazmi Güldeş, Certified Trichologist
Sources29 references
Medically reviewed byDr. Teuku Adifitrian, Sp.BP-RE (Dr. Tompi), Plastic, Reconstructive and Aesthetic Surgeon
Last reviewed30 October 2026
Last updated30 October 2026
Cite this entry
Güldeş, N. (2026, October 30). Dutasteride for hair loss: How it works and how it compares with finasteride. Turkey Hair Center Hair Library. https://turkeyhaircenter.com/dutasteride/
Spotted an error? See our corrections policy · How we use sources

Ask the Medical Team
About Your Case

Send three photos: front, top and sides. You get a technique recommendation, a graft range and a straight answer about what is achievable, before anyone talks about price.

Please tell us your name.
We need a number the medical team can reach you on.
That email address does not look right.
Country * Please choose your country.
Which area concerns you most?
Treatment you are asking about
0 / 500

Your details go straight to the patient coordination team and are stored confidentially. We never share them with third parties.

We typically reply within minutes, 24/7.

Your details are with the team

A patient coordinator will get back to you shortly. If you would like to send your photos now, WhatsApp is the fastest way to do it.

Turkey Hair Center patient coordinator Real People
Real Support
  • Send your photos on WhatsApp

    Front, top and both sides, reviewed by the medical team.

  • Call us directly

    Speak to a patient coordinator on the phone.

    +90 545 249 91 04
  • 24/7 patient support

    We respond quickly, day or night, in your language.

    Multilingual team, no obligation
Data protectedKVKK and GDPR compliant, 100% confidential

Explore the Hair Library

78 entries, 46 glossary terms and every source linked to PubMed. Pick a topic and keep reading.

Authorized Health Tourism Intermediary

Turkey Hair Center is the hair-restoration brand of Healthy Way Tourism, an authorized international health-tourism intermediary.
All medical procedures are performed by licensed medical professionals at authorized healthcare facilities in Turkiye, in accordance with the regulations of the Ministry of Health.

About our authorisation